Belando, Roselyn .
HRN: 27-37-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 500MG (TAB)
06/24/2025
07/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines